NCT02898610.

Study name	CCOlchicine for the preventioN of Vascular Inflammation in Non CardioEmbolic Stroke (CONVINCE)
Methods	Prospective, open‐label, blinded endpoint design
Participants	Adults over 40 years of age who have suffered an ischaemic stroke or TIA (72 hours to 28 days before randomisation) not caused by cardiac embolism or other defined causes
Interventions	Colchicine 0.5 mg od plus usual care vs usual care alone
Outcomes	Recurrence of non‐fatal ischaemic stroke, non‐fatal hospitalisation for unstable angina, MI, cardiac arrest, or vascular death
Starting date	December 2016
Contact information	isctn@ucd.ie
Notes	−

od: once per day.
MI: myocardial infarction.
TIA: transient ischaemic attack.